← Back
▼ SELL 10b5-1 Plan

$ Value

$354K

Shares

9,220

Price

$38

Filed

Apr 14

Insider

Name

Saggar Rajeev

Title

Chief Medical Officer

CIK

0001935638

Roles

Officer

Transaction Details

Transaction Date

2026-04-13

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

173,270

Footnotes

Performance stock units ("PSUs") convert into common stock on a one-for-one basis. | On January 11, 2024, the Reporting Person was granted 56,492 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 31,777 have vested as of the date of this Form 4. | Includes (i) 15,625 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 24,715 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 49,349 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,213 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. | On January 11, 2025, the Reporting Person was granted 71,780 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 22,431 have vested as of the date of this Form 4. | Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. | These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025.

Filing Info

Accession No.

0001104659-26-043265

Form Type

4

Issuer CIK

0001819576

Saggar Rajeev's History

Date Ticker Type Value
2026-04-13 LQDA $354K
2026-04-10 LQDA M
2026-04-10 LQDA M
2026-04-10 LQDA M $0
2026-04-10 LQDA M $0
2026-01-16 LQDA A $0
2026-01-16 LQDA A $0
2026-01-12 LQDA $791K
2026-01-09 LQDA M
2026-01-09 LQDA M

Other Insiders at LQDA (90d)

Insider Bought Sold Last
JEFFS ROGER
Chief Executive Officer
$6.0M 2026-04-17
Bloch Stephen M $2.5M 2026-03-27
Manning Paul B 2026-02-11
Kaseta Michael
CFO and COO
$12.8M 2026-04-15
Adair Jason
Chief Business Officer
$330K 2026-04-13
Moomaw Scott
Chief Commercial Officer
$1.1M 2026-04-13
Schundler Russell
General Counsel
$558K 2026-04-13
Saggar Rajeev
Chief Medical Officer
2026-04-10
Boyle Dana
Chief Accounting Officer
$275K 2026-04-13
Krepp Sarah
Chief Human Resource Officer
$183K 2026-04-13